Mild mitral regurgitation was associated with increased prevalence of thromboembolic events in patients with nonrheumatic atrial fibrillation

International Journal of Cardiology

Volumn 72, Issue 3, 2000, Pages 229-233

  Miyasaka, Yoko ^a   Tsuji, Hisako ^a   Tokunaga, Satoshi ^a   Nishiue, Takashi ^a   Yamada, Koichi ^a   Watanabe, Junko ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Mitral regurgitation; Thromboembolism

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONGENITAL HEART DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; THROMBOEMBOLISM;

AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 0033972131     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00208-9     Document Type: Article

References (16)

1. Wolf P.A., Dawber T.R., Thomas H.E., Kannel W.B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology. 28:1978;973-977.
2. Predictors of thromboembolism in atrial fibrillation: I. clinical features of patients at risk. Ann Intern Med. 116:1992;1-5.
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 154:1994;1449-1457.
4. Tsai L.M., Chen J.H., Fang C.J., Lin L.J., Kwan C.M. Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol. 70:1992;327-331.
5. Movsowitz C., Movsowitz H.D., Jacobs L.E., Meyerowitz C.B., Podolsky L.A., Kotler M.N. Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography. J Am Soc Echocardiogr. 6:1993;107-114.
6. Karatasakis G.T., Gotsis A.C., Cokkinos D.V. Influence of mitral regurgitation on left atrial thrombus and spontaneous echocardiographic contrast in patients with rheumatic mitral valve disease. Am J Cardiol. 76:1995;279-281.
7. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. New Engl J Med. 323:1990;1505-1511.
8. Predictors of thromboembolism in atrial fibrillation:II. echocardiographic features of patients at risk. Ann Intern Med. 116:1992;6-12.
9. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 58:1978;1072-1083.
10. Helmcke F., Nanda N.C., et al., Hsiung M.C. Color doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 75:1987;175-183.
11. SAS/STAT user's guide, version 6, 4th ed. vol. 2. Cary NC: SAS Institute Inc., 1989:1071-1126.
12. Shah A.B., Beamer N., Coull B.M. Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke. 16:1985;643-647.
13. Tse H.F., Lau C.P., Cheng G. Relation between mitral regurgitation and platelet activation. J Am Coll Cardiol. 30:1997;1813-1818.
14. Shively B.K., Gelgand E.A., Crawford M.H. Regional left atrial stasis during atrial fibrillation and flutter: determinants and relation to stroke. J Am Coll Cardiol. 27:1996;1722-1729.
15. Blackshear J.L., Pearce L.A., Asinger R.W., et al. Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Am J Cardiol. 72:1993;840-843.
16. Fatkin D., Kelly R.P., Feneley M.P. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 23:1994;961-969.